1.11 USD
▲+0.04+3.49%
盘后 0.93 0.00%
2026-09-16
市值
$28.00M
市盈率
—
EPS
-0.28
股息率
—
52 周区间
0.71 – 3.40
成交量
171.49K
Beta
0.61
目标价
—
52W 低 0.7152W 高 3.40
价格走势
公司简介
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ...